verified SJR 3,571 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed

United Kingdom · Springer Science and Busines...

workspace_premium Q1 — Molecular Medicine verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

EMBO Molecular Medicine

EMBO Molecular Medicine is a journal indexed in SJR in Molecular Medicine with an H index of 151. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 3300 €. The scope of the journal is focused on molecular medicine, molecular pathology, genetic processes, regenerative medicine, systems medicine, molecular biology. It has an SJR impact factor of 3,571 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,571.

EMBO Molecular Medicine focuses its scope in these topics and keywords: network, human, genetic, ftd, als, disease, phenotypes, proteomic, resolves, clinical, ...

ISSN: 1757-4676

Publisher: Springer Science and Business Media Deutschland GmbH

Category: Molecular Medicine

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

3,571 Q1

H-index 151

Acceptance rate pie_chart

23% Selective

Source Acceptance_Rate

Time to publication hourglass_top

21 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

3.300 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

3,571

H-index

151

Docs (year)

160

Docs 3y

458

Total refs

9516

Cites 3y

3597

Citable 3y

401

Cites/Doc 2y

7.02

Ref/Doc

59.48

Immediate OA

3300 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Alterations in cardiac DNA methylation in human dilated cardiomyopathy

ZNF703gene amplification at 8p12 specifies luminal B breast cancer

Consequence of the tumor-associated conversion to cyclin D1b

Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway

Cardiac

Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms

Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy

Block of K

beta-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment

Anti-tumor effects of

An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice

SHOW MORE ARTICLES

Altered gamma-secretase activity in mild cognitive impairment and Alzheimer's disease

5-HT

Activation of

Acquisition of chromosome instability is a mechanism to evade oncogene addiction

Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes

AAV

A streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury

A novel thermoregulatory role for

A novel epigenetic

A nonsense mutation of human

A high-resolution genomic analysis of multidrug-resistant hospital outbreaks of

A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases

FAQs

EMBO Molecular Medicine has an SJR of 3,571 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3300 EUR.

The acceptance rate recorded for EMBO Molecular Medicine is 23%.

EMBO Molecular Medicine

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of EMBO Molecular Medicine?

What is the APC / publication cost?

What is the acceptance rate?